Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Income towards Parent Company: 2010-2025

Historic Income towards Parent Company for Catalyst Pharmaceuticals (CPRX) over the last 15 years, with Sep 2025 value amounting to $52.8 million.

  • Catalyst Pharmaceuticals' Income towards Parent Company rose 20.28% to $52.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $217.1 million, marking a year-over-year increase of 65.79%. This contributed to the annual value of $163.4 million for FY2024, which is 174.43% up from last year.
  • According to the latest figures from Q3 2025, Catalyst Pharmaceuticals' Income towards Parent Company is $52.8 million, which was up 1.30% from $52.1 million recorded in Q2 2025.
  • In the past 5 years, Catalyst Pharmaceuticals' Income towards Parent Company registered a high of $56.7 million during Q1 2025, and its lowest value of -$30.8 million during Q3 2023.
  • Moreover, its 3-year median value for Income towards Parent Company was $40.8 million (2024), whereas its average is $35.0 million.
  • Its Income towards Parent Company has fluctuated over the past 5 years, first tumbled by 235.24% in 2023, then soared by 242.65% in 2024.
  • Over the past 5 years, Catalyst Pharmaceuticals' Income towards Parent Company (Quarterly) stood at $9.3 million in 2021, then surged by 173.62% to $25.5 million in 2022, then declined by 9.82% to $23.0 million in 2023, then soared by 141.33% to $55.4 million in 2024, then rose by 20.28% to $52.8 million in 2025.
  • Its Income towards Parent Company stands at $52.8 million for Q3 2025, versus $52.1 million for Q2 2025 and $56.7 million for Q1 2025.